Fig. 2From: Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancerSurvival curves for disease-free survival and overall survival in the two treatment arms. Shaded areas represent 95 % Hall-Wellner bandsBack to article page